<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37178769</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1538-7836</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Journal of thrombosis and haemostasis : JTH</Title><ISOAbbreviation>J Thromb Haemost</ISOAbbreviation></Journal><ArticleTitle>Thromboinflammation in long COVID-the elusive key to postinfection sequelae?</ArticleTitle><Pagination><StartPage>2020</StartPage><EndPage>2031</EndPage><MedlinePgn>2020-2031</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jtha.2023.04.039</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1538-7836(23)00400-2</ELocationID><Abstract><AbstractText>Long COVID is a public health emergency affecting millions of people worldwide, characterized by heterogeneous symptoms across multiple organ systems. Here, we discuss the current evidence linking thromboinflammation to postacute sequelae of COVID-19. Studies have found persistence of vascular damage with increased circulating markers of endothelial dysfunction, coagulation abnormalities with heightened thrombin generation capacity, and abnormalities in platelet counts in postacute sequelae of COVID-19. Neutrophil phenotype resembles acute COVID-19 with an increase in activation and Neutrophil Extracellular Trap formation. These insights are potentially linked by elevated platelet-neutrophil aggregate formation. This hypercoagulable state in turn can lead to microvascular thrombosis, evidenced by microclots and elevated D-dimer in the circulation as well as perfusion abnormalities in the lungs and brains of patients with long COVID. Also, COVID-19 survivors experience an increased rate of arterial and venous thrombotic events. We discuss 3 important, potentially intertwined hypotheses that might contribute to thromboinflammation in long COVID: lasting structural changes, most prominently endothelial damage, caused during initial infection; a persistent viral reservoir; and immunopathology driven by a misguided immune system. Finally, we outline the necessity for large, well-characterized clinical cohorts and mechanistic studies to clarify the contribution of thromboinflammation to long COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nicolai</LastName><ForeName>Leo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine I, University Hospital, LMU Munich, Munich, Germany; DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Germany. Electronic address: leo.nicolai@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaiser</LastName><ForeName>Rainer</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medicine I, University Hospital, LMU Munich, Munich, Germany; DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stark</LastName><ForeName>Konstantin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Medicine I, University Hospital, LMU Munich, Munich, Germany; DZHK (German Center for Cardiovascular Research), partner site Munich Heart Alliance, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Thromb Haemost</MedlineTA><NlmUniqueID>101170508</NlmUniqueID><ISSNLinking>1538-7836</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Thromb Haemost. 2023 Aug;21(8):2061-2063. doi: 10.1016/j.jtha.2023.05.018</RefSource><PMID Version="1">37468178</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="Y">Thrombosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000090882" MajorTopicYN="N">Thromboinflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">platelets</Keyword><Keyword MajorTopicYN="N">thromboinflammation</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>Declaration of competing interests There are no competing interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37178769</ArticleId><ArticleId IdType="pmc">PMC10174338</ArticleId><ArticleId IdType="doi">10.1016/j.jtha.2023.04.039</ArticleId><ArticleId IdType="pii">S1538-7836(23)00400-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Modin D., Claggett B., Sindet-Pedersen C., Lassen M.C.H., Skaarup K.G., Jensen J.U.S., Fralick M., Schou M., Lamberts M., Gerds T., Fosb&#xf8;l E.L., Phelps M., Kragholm K.H., Andersen M.P., K&#xf8;ber L., Torp-Pedersen C., Solomon S.D., Gislason G., Biering-S&#xf8;rensen T. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction. Circulation. 2020;142:2080&#x2013;2082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682795</ArticleId><ArticleId IdType="pubmed">33054349</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ani F., Chehade S., Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020;192:152&#x2013;160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255332</ArticleId><ArticleId IdType="pubmed">32485418</ArticleId></ArticleIdList></Reference><Reference><Citation>Dybowska M., Wyrostkiewicz D., Opoka L., Lewandowska K., Sobiecka M., Tomkowski W., Szturmowicz M. Venous thromboembolic disease in COVID-19, pathophysiology, therapy and prophylaxis. Int J Mol Sci. 2022;23</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9499629</ArticleId><ArticleId IdType="pubmed">36142282</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Paz L., Talasaz A.H., Sadeghipour P., Potpara T.S., Aronow H.D., Jara-Palomares L., Sholzberg M., Angiolillo D.J., Lip G.Y.H., Bikdeli B. COVID-19-associated pulmonary embolism: review of the pathophysiology, epidemiology, prevention, diagnosis, and treatment. Semin Thromb Hemost. 2022</Citation><ArticleIdList><ArticleId IdType="pubmed">36223804</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127.</Citation><ArticleIdList><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X. COVID-19: immunopathology and its implications for therapy. Nat Rev Immunol. 2020;20:269&#x2013;270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7143200</ArticleId><ArticleId IdType="pubmed">32273594</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T., Warkentin T.E., Thachil J., Levi M., Levy J.H. Proposal of the definition for COVID-19-associated coagulopathy. J&#xa0;Clin Med. 2021:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7827226</ArticleId><ArticleId IdType="pubmed">33430431</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A., Vecchi&#xe9; A., Dagna L., Martinod K., Dixon D.L., Van Tassell B.W., Dentali F., Montecucco F., Massberg S., Levi M., Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21:319&#x2013;329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., Li W.W., Li V.W., Mentzer S.J., Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N&#xa0;Engl J Med. 2020;383:120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogdanov V.Y., Khirmanov V.N. SARS-CoV-2, platelets, and endothelium: coexistence in space and time, or a pernicious m&#xe9;nage &#xe0; trois? Vasc Biol. 2022;4:R35&#x2013;R43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9354055</ArticleId><ArticleId IdType="pubmed">35949299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser R., Leunig A., Pekayvaz K., Popp O., Joppich M., Polewka V., Escaig R., Anjum A., Hoffknecht M.-L., Gold C., Brambs S., Engel A., Stockhausen S., Knottenberg V., Titova A., Haji M., Scherer C., Muenchhoff M., Hellmuth J.C., Saar K., et al. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19. JCI Insight. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8492337</ArticleId><ArticleId IdType="pubmed">34403366</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L., Leunig A., Brambs S., Kaiser R., Weinberger T., Weigand M., Muenchhoff M., Hellmuth J.C., Ledderose S., Schulz H., Scherer C., Rudelius M., Zoller M., H&#xf6;chter D., Keppler O., Teupser D., Zwi&#xdf;ler B., von Bergwelt-Baildon M., K&#xe4;&#xe4;b S., Massberg S., et al. Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy. Circulation. 2020;142:1176&#x2013;1189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7497892</ArticleId><ArticleId IdType="pubmed">32755393</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L., Leunig A., Brambs S., Kaiser R., Joppich M., Hoffknecht M., Gold C., Engel A., Polewka V., Muenchhoff M., Hellmuth J.C., Ruhle A., Ledderose S., Weinberger T., Schulz H., Scherer C., Rudelius M., Zoller M., Keppler O.T., Zwi&#xdf;ler B., et al. Vascular neutrophilic inflammation and immunothrombosis distinguish severe COVID-19 from influenza pneumonia. J&#xa0;Thromb Haemost. 2021;19:574&#x2013;581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753335</ArticleId><ArticleId IdType="pubmed">33217134</ArticleId></ArticleIdList></Reference><Reference><Citation>Meizlish M.L., Pine A.B., Bishai J.D., Goshua G., Nadelmann E.R., Simonov M., Chang C.H., Zhang H., Shallow M., Bahel P., Owusu K., Yamamoto Y., Arora T., Atri D.S., Patel A., Gbyli R., Kwan J., Won C.H., Dela Cruz C., Price C., et al. A&#xa0;neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021;5:1164&#x2013;1177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7908851</ArticleId><ArticleId IdType="pubmed">33635335</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton E.A., He X.-Y., Denorme F., Campbell R.A., Ng D., Salvatore S.P., Mostyka M., Baxter-Stoltzfus A., Borczuk A.C., Loda M., Cody M.J., Manne B.K., Portier I., Harris E.S., Petrey A.C., Beswick E.J., Caulin A.F., Iovino A., Abegglen L.M., Weyrich A.S., et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood. 2020;136:1169&#x2013;1179.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzali B., Noris M., Lambrecht B.N., Kemper C. The state of complement in COVID-19. Nat Rev Immunol. 2022;22:77&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8672651</ArticleId><ArticleId IdType="pubmed">34912108</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvelli J., Demaria O., V&#xe9;ly F., Batista L., Chouaki B.N., Fares J., Carpentier S., Thibult M.-L., Morel A., Remark R., Andr&#xe9; P., Represa A., Piperoglou C. the Explore COVID-19 IPH group, the Explore COVID-19 Marseille Immunopole group, Cordier PY, Le Dault E, Guervilly C, Simeone P, Gainnier M, et&#xa0;al. Association of COVID-19 inflammation with activation of the C5a&#x2013;C5aR1 axis. Nature. 2020;588:146&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116884</ArticleId><ArticleId IdType="pubmed">32726800</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway E.M., Mackman N., Warren R.Q., Wolberg A.S., Mosnier L.O., Campbell R.A., Gralinski L.E., Rondina M.T., van de Veerdonk F.L., Hoffmeister K.M., Griffin J.H., Nugent D., Moon K., Morrissey J.H. Understanding COVID-19-associated coagulopathy. Nat Rev Immunol. 2022;22:639&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9362465</ArticleId><ArticleId IdType="pubmed">35931818</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark K., Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021;18:666&#x2013;682.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8100938</ArticleId><ArticleId IdType="pubmed">33958774</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO coronavirus (COVID-19) dashboard. https://covid19.who.int/ 2020 [accessed May 28, 2023].</Citation></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J&#xa0;Infect Dis. 2022;226:1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374:n1648.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Samranvedhya J., Lipsitch M., Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373:n1098.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B., Bluemke D.A., L&#xfc;scher T.F., Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022;43:1157&#x2013;1172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Martin S., Shchendrygina A., Hoffmann J., Ka M.M., Giokoglu E., Vanchin B., Holm N., Karyou A., Laux G.S., Arendt C., De Leuw P., Zacharowski K., Khodamoradi Y., Vehreschild M.J.G.T., Rohde G., Zeiher A.M., Vogl T.J., Schwenke C., Nagel E. Long-term cardiac pathology in individuals with mild initial COVID-19 illness. Nat Med. 2022;28:2117&#x2013;2123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9556300</ArticleId><ArticleId IdType="pubmed">36064600</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., Huggins C.F., Kwong A.S.F., Silverwood R.J., Di Gessa G., Bowyer R.C.E., Northstone K., Hou B., Green M.J., Dodgeon B., Doores K.J., Duncan E.L., Williams F.M.K., OpenSAFELY Collaborative, Steptoe A., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13:3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-P&#xe9;rez O., Merino E., Leon-Ramirez J.-M., Andres M., Ramos J.M., Arenas-Jim&#xe9;nez J., Asensio S., Sanchez R., Ruiz-Torregrosa P., Galan I., Scholz A., Amo A., Gonz&#xe1;lez-delaAleja P., Boix V., Gil J., COVID19-ALC research group Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J&#xa0;Infect. 2021;82:378&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamal M., Abo Omirah M., Hussein A., Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7536922</ArticleId><ArticleId IdType="pubmed">32991035</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., Molteni E., Modat M., Jorge Cardoso M., May A., Ganesh S., Davies R., Nguyen L.H., Drew D.A., Astley C.M., Joshi A.D., et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Willyard C. Could tiny blood clots cause long COVID&#x2019;s puzzling symptoms? Nature. 2022;608:662&#x2013;664.</Citation><ArticleIdList><ArticleId IdType="pubmed">36002482</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Townsend L., Morrin H., Ahmad A., Comerford C., Karampini E., Englert H., Byrne M., Bergin C., O&#x2019;Sullivan J.M., Martin-Loeches I., Nadarajan P., Bannan C., Mallon P.W., Curley G.F., Preston R.J.S., Rehill A.M., McGonagle D., Ni Cheallaigh C., Baker R.I., et al. Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J&#xa0;Thromb Haemost. 2021;19:2546&#x2013;2553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20:172.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahamed J., Laurence J. Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches. J&#xa0;Clin Invest. 2022:132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9337829</ArticleId><ArticleId IdType="pubmed">35912863</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty H., Ward S.E., Townsend L., Karampini E., Elliott S., Conlon N., Dunne J., Kiersey R., Naughton A., Gardiner M., Byrne M., Bergin C., O&#x2019;Sullivan J.M., Martin-Loeches I., Nadarajan P., Bannan C., Mallon P.W., Curley G.F., Preston R.J.S., Rehill A.M., et al. Sustained VWF-ADAMTS-13 axis imbalance and endotheliopathy in long COVID syndrome is related to immune dysfunction. J&#xa0;Thromb Haemost. 2022;20:2429&#x2013;2438.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9349977</ArticleId><ArticleId IdType="pubmed">35875995</ArticleId></ArticleIdList></Reference><Reference><Citation>Masias C., Cataland S.R. The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis. Blood, The Journal of the American Society of Hematology. 2018;132:903&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">30006329</ArticleId></ArticleIdList></Reference><Reference><Citation>Favaloro E.J., Henry B.M., Lippi G. 4th&#xa0;ed. Thieme Medical Publishers Inc; The Journal of the American Society of Hematology; Washington: 2018. Increased VWF and decreased ADAMTS-13 in COVID-19: creating a milieu for (micro) thrombosis; pp. 400&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pubmed">33893632</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarado-Moreno J.A., Davila-Moreno J., Dominguez-Reyes V., Arreola-Diaz R., Isordia-Salas I., Chavez-Gonzalez A., Majluf-Cruz A. Morphological and functional alterations in endothelial colony-forming cells from recovered COVID-19 patients. Thromb Res. 2021;206:55&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363179</ArticleId><ArticleId IdType="pubmed">34411875</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyatos P., Luque N., Eizaguirre S., Sabater G., Sebasti&#xe1;n L., &#xcd; Francisco-Albesa, Peracaula M., Boixad&#xe9; M., Orriols R., Tura-Ceide O. Post-COVID-19 patients show an increased endothelial progenitor cell production. Transl Res. 2022;243:14&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8785258</ArticleId><ArticleId IdType="pubmed">35085821</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine S., Ibn Hadj Amor H., Jdidi J., Torjmen S., Kraiem S., Hammami R., Bahloul A., Kallel N., Moussa N., Touil I., Ghrab A., Elghoul J., Meddeb Z., Thabet Y., Kammoun S., Bouslama K., Milouchi S., Abdessalem S., Abid L. Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front Cardiovasc Med. 2021;8:1702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow A.J., Sykes R., McIntosh A., Kamdar A., Bagot C., Bayes H.K., Blyth K.G., Briscoe M., Bulluck H., Carrick D., Church C., Corcoran D., Findlay I., Gibson V.B., Gillespie L., Grieve D., Hall Barrientos P., Ho A., Lang N.N., Lennie V., et al. A&#xa0;multisystem, cardio-renal investigation of post-COVID-19 illness. Nat Med. 2022;28:1303&#x2013;1313.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9205780</ArticleId><ArticleId IdType="pubmed">35606551</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherbakov N., Szklarski M., Hartwig J., Sotzny F., Lorenz S., Meyer A., Grabowski P., Doehner W., Scheibenbogen C. Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. ESC Heart Fail. 2020;7:1064&#x2013;1071.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261521</ArticleId><ArticleId IdType="pubmed">32154656</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton D.J., Kennedy G., Chan K.K.F., Lang C.C., Belch J.J.F., Khan F. Large and small artery endothelial dysfunction in chronic fatigue syndrome. Int J Cardiol. 2012;154:335&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pubmed">22078396</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng S.-Y., Xiao Q.-Y., Xie X.-H., Deng Y., Ren L., Tian D.-Y., Luo Z.-X., Luo J., Fu Z., Huang A.-L., Liu E.M. Association between secondary thrombocytosis and viral respiratory tract infections in children. Sci Rep. 2016;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4786797</ArticleId><ArticleId IdType="pubmed">26965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S.O., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID/post-acute sequelae of COVID-19 (PASC) Cardiovasc Diabetol. 2022;21:148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Martins-Gon&#xe7;alves R., Campos M.M., Palhinha L., Azevedo-Quintanilha I.G., Abud Mendes M., Ramos Temerozo J., Toledo-Mendes J., Rosado-de-Castro P.H., Bozza F.A., Souza Rodrigues R., Hottz E.D., Bozza P.T. Persisting platelet activation and hyperactivity in COVID-19 survivors. Circ Res. 2022;131:944&#x2013;947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9645447</ArticleId><ArticleId IdType="pubmed">36268747</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S, Naidoo CA, Usher TJ, Kruger A, Venter C, Laubscher GJ, Khan MA, Kell DB, Pretorius E. Increased levels of inflammatory molecules in blood of long COVID patients point to thrombotic endotheliitis. medRxiv 2022:2022.10.13.22281055.</Citation><ArticleIdList><ArticleId IdType="pubmed">37207671</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G., Norris G., Spence V., McLaren M., Belch J.J.F. Is chronic fatigue syndrome associated with platelet activation? Blood Coagul Fibrinolysis. 2006;17:89&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">16479189</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg D., Berg L.H., Couvaras J., Harrison H. Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis. Blood Coagul Fibrinolysis. 1999;10:435&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">10695770</ArticleId></ArticleIdList></Reference><Reference><Citation>Dean L.S., Devendra G., Jiyarom B., Subia N., Tallquist M.D., Nerurkar V.R., Chang S.P., Chow D.C., Shikuma C.M., Park J. Phenotypic alteration of low-density granulocytes in people with pulmonary post-acute sequalae of SARS-CoV-2 infection. Front Immunol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9797994</ArticleId><ArticleId IdType="pubmed">36591237</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisareva E., Badiou S., Mihalovi&#x10d;ov&#xe1; L., Mirandola A., Pastor B., Kudriavtsev A., Berger M., Roubille C., Fesler P., Klouche K., Cristol J.P., Thierry A.R. Persistence of neutrophil extracellular traps and anticardiolipin auto-antibodies in post-acute phase COVID-19 patients. J&#xa0;Med Virol. 2023;95</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9874393</ArticleId><ArticleId IdType="pubmed">36226380</ArticleId></ArticleIdList></Reference><Reference><Citation>George P.M., Reed A., Desai S.R., Devaraj A., Faiez T.S., Laverty S., Kanwal A., Esneau C., Liu M.K.C., Kamal F., Man W.D.C., Kaul S., Singh S., Lamb G., Faizi F.K., Schuliga M., Read J., Burgoyne T., Pinto A.L., Micallef J., et al. A&#xa0;persistent neutrophil-associated immune signature characterizes post&#x2013;COVID-19 pulmonary sequelae. Sci Transl Med. 2022;14</Citation><ArticleIdList><ArticleId IdType="pubmed">36383686</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Schrepping J., Reusch N., Paclik D., Ba&#xdf;ler K., Schlickeiser S., Zhang B., Kr&#xe4;mer B., Krammer T., Brumhard S., Bonaguro L., De Domenico E., Wendisch D., Grasshoff M., Kapellos T.S., Beckstette M., Pecht T., Saglam A., Dietrich O., Mei H.E., Schulz A.R., et al. evere COVID-19 is marked by a dysregulated myeloid cell compartment. Cell. 2020;182:1419&#x2013;1440.e23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G., Spence V., Underwood C., Belch J.J.F. Increased neutrophil apoptosis in chronic fatigue syndrome. J&#xa0;Clin Pathol. 2004;57:891&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1770396</ArticleId><ArticleId IdType="pubmed">15280416</ArticleId></ArticleIdList></Reference><Reference><Citation>von Meijenfeldt F.A., Havervall S., Adelmeijer J., Lundstr&#xf6;m A., Magnusson M., Mackman N., Thalin C., Lisman T. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 2021;5:756&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857699</ArticleId><ArticleId IdType="pubmed">33560386</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannan K.L., Berg D.E., Baumzweiger W., Harrison H.H., Berg L.H., Ramirez R., Nichols D. Activation of the coagulation system in Gulf War Illness: a potential pathophysiologic link with chronic fatigue syndrome. A laboratory approach to diagnosis. Blood Coagul Fibrinolysis. 2000;11:673&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pubmed">11085289</ArticleId></ArticleIdList></Reference><Reference><Citation>Holter J.C., Pischke S.E., de Boer E., Lind A., Jenum S., Holten A.R., Tonby K., Barratt-Due A., Sokolova M., Schjalm C., Chaban V., Kolderup A., Tran T., Tollefsrud Gj&#xf8;lberg T., Skeie L.G., Hesstvedt L., Orm&#xe5;sen V., Fevang B., Austad C., M&#xfc;ller K.E., et al. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proc Natl Acad Sci U S A. 2020;117:25018&#x2013;25025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547220</ArticleId><ArticleId IdType="pubmed">32943538</ArticleId></ArticleIdList></Reference><Reference><Citation>Colarusso C., Maglio A., Terlizzi M., Vitale C., Molino A., Pinto A., Vatrella A., Sorrentino R. Post-COVID-19 patients who develop lung fibrotic-like changes have lower circulating levels of IFN-&#x3b2; but higher levels of IL-1&#x3b1; and TGF-&#x3b2;. Biomedicines. 2021;9</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8698335</ArticleId><ArticleId IdType="pubmed">34944747</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorensen B., Streib J.E., Strand M., Make B., Giclas P.C., Fleshner M., Jones J.F. Complement activation in a model of chronic fatigue syndrome. J&#xa0;Allergy Clin Immunol. 2003;112:397&#x2013;403.</Citation><ArticleIdList><ArticleId IdType="pubmed">12897748</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J., Zacares M., Almenar-P&#xe9;rez E., Alegre-Mart&#xed;n J., Oltra E. Complement component C1q as a potential diagnostic tool for myalgic encephalomyelitis/chronic fatigue syndrome subtyping. J&#xa0;Clin Med. 2021;10:4171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8467657</ArticleId><ArticleId IdType="pubmed">34575280</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein J., Wood J., Jaycox J., Lu P., Dhodapkar R.M., Gehlhausen J.R., Tabachnikova A., Tabacof L., Malik A.A., Kamath K., Greene K., Monteiro V.S., Pe&#xf1;a-Hernandez M., Mao T., Bhattacharjee B., Takahashi T., Lucas C., Silva J., Mccarthy D., Breyman E., et al. Distinguishing features of long COVID identified through immune profiling. medRxiv. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10620090</ArticleId><ArticleId IdType="pubmed">37748514</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Henkes S.-S., Bosurgi L., Dutzmann J., Sedding D., Frese T., Girndt M., H&#xf6;ll J.I., Gekle M., Mikolajczyk R., Binder M. The IL-1&#x3b2;, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med. 2022;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., Kelleher A.D., Matthews G.V. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol. 2022;23:210&#x2013;216.</Citation><ArticleIdList><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze J.L., Aschenbrenner A.C. COVID-19 and the human innate immune system. Cell. 2021;184:1671&#x2013;1692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7885626</ArticleId><ArticleId IdType="pubmed">33743212</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed F., Vu L.T., Zhu H., Iu D.S.H., Fogarty E.A., Kwak Y., Chen W., Franconi C.J., Munn P.R., Levine S.M., Stevens J., Mao X., Shungu D.C., Moore G.E., Keller B.A., Hanson M.R., Grenier J.K., Grimson A. Single-cell transcriptomics of the immune system in ME/CFS at baseline and following symptom provocation. bioRxiv. 2022 10.13.512091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10829790</ArticleId><ArticleId IdType="pubmed">38232699</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitami T., Fukuda S., Kato T., Yamaguti K., Nakatomi Y., Yamano E., Kataoka Y., Mizuno K., Tsuboi Y., Kogo Y., Suzuki H., Itoh M., Morioka M.S., Kawaji H., Koseki H., Kikuchi J., Hayashizaki Y., Ohno H., Kuratsune H., Watanabe Y. Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population. Sci Rep. 2020;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7669873</ArticleId><ArticleId IdType="pubmed">33199820</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan B.E., Wong S.W., Sum C.L.L., Lim G.H., Leung B.P., Tan C.W., Ramanathan K., Dalan R., Cheung C., Lim X.R., Sadasiv M.S., Lye D.C., Young B.E., Yap E.S., Chia Y.W. COVID-19 Clotting and Bleeding Investigators. Hypercoagulability, endotheliopathy, and inflammation approximating 1 year after recovery: assessing the long-term outcomes in COVID-19 patients. Am J Hematol. 2022;97:915&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9073976</ArticleId><ArticleId IdType="pubmed">35477923</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Fogarty H., Dyer A., Martin-Loeches I., Bannan C., Nadarajan P., Bergin C., O&#x2019;Farrelly C., Conlon N., Bourke N.M., Ward S.E., Byrne M., Ryan K., O&#x2019;Connell N., O&#x2019;Sullivan J.M., Ni Cheallaigh C., O&#x2019;Donnell J.S. Prolonged elevation of D-dimer levels in convalescent COVID-19 patients is independent of the acute phase response. J&#xa0;Thromb Haemost. 2021;19:1064&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013297</ArticleId><ArticleId IdType="pubmed">33587810</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini E., Corsetti G., Romano C., Scarabelli T.M., Chen-Scarabelli C., Saravolatz L., Dioguardi F.S. Serum metabolic profile in patients with long-covid (PASC) syndrome: clinical implications. Front Med (Lausanne) 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalaivani M.K., Dinakar S. Association between D-dimer levels and post-acute sequelae of SARS-CoV-2 in patients from a tertiary care center. Biomark Med. 2022;16:833&#x2013;838.</Citation><ArticleIdList><ArticleId IdType="pubmed">35787147</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray M.A., Sartain S.E., Gollamudi J., Rumbaut R.E. Microvascular thrombosis: experimental and clinical implications. Transl Res. 2020;225:105&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7245314</ArticleId><ArticleId IdType="pubmed">32454092</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho J.L., Villacreses R., Nagpal P., Guo J., Pezzulo A.A., Thurman A.L., Hamzeh N.Y., Blount R.J., Fortis S., Hoffman E.A., Zabner J., Comellas A.P. Quantitative chest CT assessment of small airways disease in post-acute SARS-CoV-2 infection. Radiology. 2022;304:185&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9270680</ArticleId><ArticleId IdType="pubmed">35289657</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Di Giuda D., Sigfrid L., Pizzuto D.A., Di Sante G., De Rose C., Lazzareschi I., Sali M., Baldi F., Chieffo D.P.R., Munblit D., Valentini P. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child Adolesc Health. 2021;5:677&#x2013;680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324416</ArticleId><ArticleId IdType="pubmed">34339624</ArticleId></ArticleIdList></Reference><Reference><Citation>Heiss R, Wagner AL, Tan L, Regensburger AP, Schmidt S, Ewert F, Mammadova D, B&#xfc;hler A, Vogel-Claussen J, Voskrebenzev A, Rauh M, Rompel O, Nagel AM, L&#xe9;vy S, Bickelhaupt S, May MS, Uder M, Metzler M, Trollmann R, Woelfle J, et&#xa0;al. Persisting pulmonary dysfunction in pediatric post-acute covid-19. SSRN Journal.</Citation></Reference><Reference><Citation>Heiss R., Tan L., Schmidt S., Regensburger A.P., Ewert F., Mammadova D., Buehler A., Vogel-Claussen J., Voskrebenzev A., Rauh M., Rompel O., Nagel A.M., L&#xe9;vy S., Bickelhaupt S., May M.S., Uder M., Metzler M., Trollmann R., Woelfle J., Wagner A.L., Knieling F. Pulmonary dysfunction after pediatric COVID-19. Radiology. 2022;306</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513839</ArticleId><ArticleId IdType="pubmed">36125379</ArticleId></ArticleIdList></Reference><Reference><Citation>Prasannan N., Heightman M., Hillman T., Wall E., Bell R., Kessler A., Neave L., Doyle A., Devaraj A., Singh D., Dehbi H.M., Scully M. Impaired exercise capacity in post-COVID-19 syndrome: the role of VWF-ADAMTS13 axis. Blood Adv. 2022;6:4041&#x2013;4048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9098525</ArticleId><ArticleId IdType="pubmed">35543533</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Y., Wu J., Chen T., Li J., Zhang G., Wu D., Zhou Y., Zheng N., Cai A., Ning Q., Manyande A., Xu F., Wang J., Zhu W. Long-term microstructure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations. J&#xa0;Clin Invest. 2021:131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8262559</ArticleId><ArticleId IdType="pubmed">33630760</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J.L.R., Griffanti L., Duff E., Jbabdi S., Taschler B., Keating P., Winkler A.M., Collins R., Matthews P.M., Allen N., Miller K.L., Nichols T.E., Smith S.M. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604:697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Perl D.P., Steiner J., Pasternack N., Li W., Maric D., Safavi F., Horkayne-Szakaly I., Jones R., Stram M.N., Moncur J.T., Hefti M., Folkerth R.D., Nath A. Neurovascular injury with complement activation and inflammation in COVID-19. Brain. 2022;145:2555&#x2013;2568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.H., Perl D.P., Nair G., Li W., Maric D., Murray H., Dodd S.J., Koretsky A.P., Watts J.A., Cheung V., Masliah E., Horkayne-Szakaly I., Jones R., Stram M.N., Moncur J., Hefti M., Folkerth R.D., Nath A. Microvascular injury in the brains of patients with covid-19. N&#xa0;Engl J Med. 2021;384:481&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7787217</ArticleId><ArticleId IdType="pubmed">33378608</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-Casta&#xf1;eda A., Lu P., Geraghty A.C., Song E., Lee M.-H., Wood J., O&#x2019;Dea M.R., Dutton S., Shamardani K., Nwangwu K., Mancusi R., Yal&#xe7;&#x131;n B., Taylor K.R., Acosta-Alvarez L., Malacon K., Keough M.B., Ni L., Woo P.J., Contreras-Esquivel D., Toland A.M.S., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath A. Nervous system consequences of COVID-19. Science. 2022;375:267&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L., Massberg S. Platelets as key players in inflammation and infection. Curr Opin Hematol. 2020;27:34&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">31688457</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolai L., Gaertner F., Massberg S. Platelets in host defense: experimental and clinical insights. Trends Immunol. 2019;40:922&#x2013;938.</Citation><ArticleIdList><ArticleId IdType="pubmed">31601520</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu-Bercu A., Kessler A., de Groot R., Dragunaite B., Heightman M., Hillman T., Price L.C., Brennan E., Sivera R., Vanhoorelbeke K., Singh D., Scully M. Analysis of thrombogenicity under flow reveals new insights into the prothrombotic state of patients with post-COVID syndrome. J&#xa0;Thromb Haemost. 2023;21:94&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9773628</ArticleId><ArticleId IdType="pubmed">36695401</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., Kang L., Guo L., Liu M., Zhou X., Luo J., Huang Z., Tu S., Zhao Y., Chen L., Xu D., Li Y., Li C., Peng L., Li Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28:583&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannis D., Allen S.L., Tsang J., Flint S., Pinhasov T., Williams S., Tan G., Thakur R., Leung C., Snyder M., Bhatia C., Garrett D., Cotte C., Isaacs S., Gugerty E., Davidson A., Marder G.S., Schnitzer A., Goldberg B., McGinn T., et al. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood. 2021;137:2838&#x2013;2847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8032474</ArticleId><ArticleId IdType="pubmed">33824972</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight R., Walker V., Ip S., Cooper J.A., Bolton T., Keene S., Denholm R., Akbari A., Abbasizanjani H., Torabi F., Omigie E., Hollings S., North T.L., Toms R., Jiang X., Angelantonio E.D., Denaxas S., Thygesen J.H., Tomlinson C., Bray B., et al. Association of COVID-19 with major arterial and venous thrombotic diseases: a population-wide cohort study of 48 million adults in England and Wales. Circulation. 2022;146:892&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9484653</ArticleId><ArticleId IdType="pubmed">36121907</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil J. Hypoxia&#x2014;an overlooked trigger for thrombosis in COVID-19 and other critically ill patients. J&#xa0;Thromb Haemost. 2020;18:3109&#x2013;3110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9770767</ArticleId><ArticleId IdType="pubmed">32726507</ArticleId></ArticleIdList></Reference><Reference><Citation>Perico L., Benigni A., Casiraghi F., Ng L.F.P., Renia L., Remuzzi G. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17:46&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7570423</ArticleId><ArticleId IdType="pubmed">33077917</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M., Pujol J.C., Spector T.D., Ourselin S., Steves C.J. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet. 2022;399:2263&#x2013;2264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent circulating severe acute respiratory syndrome coronavirus 2 spike is associated with post-acute coronavirus disease 2019 sequelae. Clin Infect Dis. 2023;76:e487&#x2013;e490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C., Wang Z., Lorenzi J.C.C., Muecksch F., Finkin S., Tokuyama M., Cho A., Jankovic M., Schaefer-Babajew D., Oliveira T.Y., Cipolla M., Viant C., Barnes C.O., Bram Y., Breton G., H&#xe4;ggl&#xf6;f T., Mendoza P., Hurley A., Turroja M., Gordon K., et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591:639&#x2013;644.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., R&#xf6;ssler A., Kimpel J., Adolph T.E., Tilg H. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology. 2022;163:495&#x2013;506.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S.R., Ramelli S.C., Grazioli A., Chung J.-Y., Singh M., Yinda C.K., Winkler C.W., Sun J., Dickey J.M., Ylaya K., Ko S.H., Platt A.P., Burbelo P.D., Quezado M., Pittaluga S., Purcell M., Munster V.J., Belinky F., Ramos-Benitez M.J., Boritz E.A., et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte K.I., Catahay J.A., Velasco J.V., Pastrana A., Ver A.T., Pangilinan F.C., Peligro P.J., Casimiro M., Guerrero J.J., Gellaco M.M.L., Lippi G., Henry B.M., Fern&#xe1;ndez-de-Las-Pe&#xf1;as C. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. eClinicalMedicine. 2022;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannous J., Pan A.P., Potter T., Bako A., Dlouhy K., Drews A., Sostman H.D., Vahidy F.S. Real world evidence of effectiveness of COVID-19 vaccines and anti SARS-CoV-2 monoclonal antibodies against post-acute sequelae of SARS-CoV-2 infection. medRxiv. 2022:2022. 06.30.22277105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10083521</ArticleId><ArticleId IdType="pubmed">37019490</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan F.J., Hope C.M., Masavuli M.G., Lynn M.A., Mekonnen Z.A., Yeow A.E.L., Garcia-Valtanen P., Al-Delfi Z., Gummow J., Ferguson C., O&#x2019;Connor S., Reddi B.A.J., Hissaria P., Shaw D., Kok-Lim C., Gleadle J.M., Beard M.R., Barry S.C., Grubor-Bauk B., Lynn D.J. Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection. BMC Med. 2022;20:26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="pubmed">35027067</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun H.J., Coutavas E., Pine A.B., Lee A.I., Yu V.L., Shallow M.K., Giovacchini C.X., Mathews A.M., Stephenson B., Que L.G., Lee P.J., Kraft B.D. Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection. JCI Insight. 2021:6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8410030</ArticleId><ArticleId IdType="pubmed">34111030</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., Kornilov S.A., Scherler K., Pavlovitch-Bedzyk A.J., Dong S., Lausted C., Lee I., Fallen S., Dai C.L., Baloni P., Smith B., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Deveau T.-M., Munter S.E., Ryder D., Buck A., Beck-Engeser G., Chan F., Lu S., Goldberg S.A., Hoh R., Tai V., Torres L., Iyer N.S., Deswal M., Ngo L.H., Buitrago M., Rodriguez A., Chen J.Y., Yee B.C., Chenna A., et al. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J&#xa0;Clin Invest. 2023:133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9888380</ArticleId><ArticleId IdType="pubmed">36454631</ArticleId></ArticleIdList></Reference><Reference><Citation>Moores L.K., Tritschler T., Brosnahan S., Carrier M., Collen J.F., Doerschug K., Holley A.B., Jimenez D., Le Gal G., Rali P., Wells P. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest. 2020;158:1143&#x2013;1163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7265858</ArticleId><ArticleId IdType="pubmed">32502594</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuker A., Tseng E.K., Nieuwlaat R., Angchaisuksiri P., Blair C., Dane K., Davila J., DeSancho M.T., Diuguid D., Griffin D.O., Kahn S.R., Klok F.A., Lee A.I., Neumann I., Pai A., Righini M., Sanfilippo K.M., Siegal D., Skara M., Terrell D.R., et al. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis. Blood Adv. 2022;6:664&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8566097</ArticleId><ArticleId IdType="pubmed">34727173</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28:1461&#x2013;1467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E., Han A.X., Boyd A., van Willigen H.D.G., Verveen A., Lebbink R., van der Straten K., Kootstra N., van Gils M.J., Russell C., Leenstra T., de Jong M.D., de Bree G.J., Prins M. RECoVERED Study Group. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): a prospective cohort study. Vaccine. 2022;40:4424&#x2013;4431.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. BMJ. 2022;377</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammond J., Leister-Tebbe H., Gardner A., Abreu P., Bao W., Wisemandle W., Baniecki M., Hendrick V.M., Damle B., Sim&#xf3;n-Campos A., Pypstra R., Rusnak J.M. EPIC-HR Investigators. Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19. N&#xa0;Engl J Med. 2022;386:1397&#x2013;1408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8908851</ArticleId><ArticleId IdType="pubmed">35172054</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Anglin K., Durstenfeld M.S., Martin J.N., Kelly J.D., Hsue P.Y., Henrich T.J., Deeks S.G. Effect of oral nirmatrelvir on long COVID symptoms: 4 cases and rationale for systematic studies. Pathog Immun. 2022;7:95&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9254867</ArticleId><ArticleId IdType="pubmed">35800257</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Choi T., Al-Aly Z. Nirmatrelvir and the risk of post-acute sequelae of COVID-19. medRxiv. 2022:2022. 11.03.22281783.</Citation></Reference><Reference><Citation>Forshaw D., Wall E.C., Prescott G., Dehbi H.-M., Green A., Attree E., Hismeh L., Strain W.D., Crooks M.G., Watkins C. STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with long COVID: a structured protocol. medRxiv. 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9931100</ArticleId><ArticleId IdType="pubmed">36791116</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis S., Popp M., Schie&#xdf;er S., Metzendorf M.-I., Kranke P., Meybohm P., Weibel S. Anticoagulation in COVID-19 patients&#x2013; an updated systematic review and meta-analysis. Thromb Res. 2022;219:40&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9451936</ArticleId><ArticleId IdType="pubmed">36113402</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffieux H., Hanson A.L., Lodge S., Lawler N.G., Whiley L., Gray N., Nolan T.H., Bergamaschi L., Mescia F., Turner L., de Sa A., Pelly V.S., Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) BioResource COVID-19 Collaboration. Kotagiri P., Kingston N., Bradley J.R., Holmes E., Wist J., Nicholson J.K., Lyons P.A., et al. A&#xa0;patient-centric modeling framework captures recovery from SARS-CoV-2 infection. Nat Immunol. 2023;24:349&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9892000</ArticleId><ArticleId IdType="pubmed">36717723</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute of Health Research. The PRECIOUS study, https://www.preciouscovidoutcomes.org; 2023 [accessed May 28, 2023].</Citation></Reference><Reference><Citation>Haffke M., Freitag H., Rudolf G., Seifert M., Doehner W., Scherbakov N., Hanitsch L., Wittke K., Bauer S., Konietschke F., Paul F., Bellmann-Strobl J., Kedor C., Scheibenbogen C., Sotzny F. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS) J&#xa0;Transl Med. 2022;20:138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8938726</ArticleId><ArticleId IdType="pubmed">35317812</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., Serafini R.A., Pryce K.D., Zazhytska M., Oishi K., Golynker I., Panis M., Zimering J., Horiuchi S., Hoagland D.A., M&#xf8;ller R., Ruiz A., Kodra A., Overdevest J.B., Canoll P.D., Borczuk A.C., Chandar V., Bram Y., Schwartz R., Lomvardas S., et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci Transl Med. 2022;14</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen E.B., Orvold S.N., Swan C.L., Yourkowski A., Thivierge B.M., Francis M.E., Ge A., Rioux M., Darbellay J., Howland J.G., Kelvin A.A. After the virus has cleared&#x2014;can preclinical models be employed for long COVID research? PLOS Pathog. 2022;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9451097</ArticleId><ArticleId IdType="pubmed">36070309</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>